Comparison of global myocardial strain assessed by cardiovascular magnetic resonance tagging and feature tracking to infarct size at predicting remodelling following STEMI.
posted on 2017-03-09, 12:30authored byAbhishek M. Shetye, Sheraz A. Nazir, Naveed A. Razvi, Nathan Price, Jamal N. Khan, Florence Y. Lai, Iain B. Squire, Gerald P. McCann, Jayanth R. Arnold
BACKGROUND: To determine if global strain parameters measured by cardiovascular magnetic resonance (CMR) acutely following ST-segment Elevation Myocardial Infarction (STEMI) predict adverse left ventricular (LV) remodelling independent of infarct size (IS). METHODS: Sixty-five patients with acute STEMI (mean age 60 ± 11 years) underwent CMR at 1-3 days post-reperfusion (baseline) and at 4 months. Global peak systolic circumferential strain (GCS), measured by tagging and Feature Tracking (FT), and global peak systolic longitudinal strain (GLS), measured by FT, were calculated at baseline, along with IS. On follow up scans, volumetric analysis was performed to determine the development of adverse remodelling - a composite score based on development of either end-diastolic volume index [EDVI] ≥20% or end-systolic volume index [ESVI] ≥15% at follow-up compared to baseline. RESULTS: The magnitude of GCS was higher when measured using FT (-21.1 ± 6.3%) than with tagging (-12.1 ± 4.3; p < 0.001 for difference). There was good correlation of strain with baseline LVEF (r 0.64-to 0.71) and IS (ρ -0.62 to-0.72). Baseline strain parameters were unable to predict development of adverse LV remodelling. Only baseline IS predicted adverse remodelling - Odds Ratio 1.05 (95% CI 1.01-1.10, p = 0.03), area under the ROC curve 0.70 (95% CI 0.52-0.87, p = 0.04). CONCLUSION: Baseline global strain by CMR does not predict the development of adverse LV remodelling following STEMI.
Funding
British Heart Foundation (BHF), National Institute for Health Research (NIHR), and the University of Leicester, United Kingdom. This work is part of a student (AS) Bachelor of Science project funded by the University of Leicester and the NIHR (GPM is supported by a NIHR Postdoctoral Research Fellowship). All patients were recruited as part of a previous project grant funded by the BHF (Title: Plasma matrix metalloproteinase and tissue inhibitor of metalloproteinase after acute myocardial infarction in man: a cardiac magnetic resonance study of left ventricular remodelling – Grant number: PG /08/082/ 2572) and the NIHR Leicester Cardiovascular Biomedical Research Unit.
History
Citation
BMC Cardiovascular Disorders, 2017, 17 (1)
Author affiliation
/Organisation/COLLEGE OF MEDICINE, BIOLOGICAL SCIENCES AND PSYCHOLOGY/School of Medicine/Department of Cardiovascular Sciences
All data generated or analysed during this study are included in this published article. Raw data for the study is stored and archived and is available upon request.